Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242015441 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Lara Boucher und 10 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Poitiers, Service de Cancérologie Biologique, F86000 Poitiers, France. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acute myeloid leukemia (AML) with BCR::ABL1 has recently been recognized as a distinct subtype in international classifications. Distinguishing it from myeloid blast crisis chronic myeloid leukemia (BC-CML) without evidence of a chronic phase (CP), remains challenging. We aimed to better characterize this entity by integrating clonal architecture analysis, mutational landscape assessment, and gene expression profiling. We analyzed a large retrospective cohort study including CML and AML patients. Two AML patients harboring a BCR::ABL1 fusion were included in the study. We identified BCR::ABL1 fusion as a primary event in one patient and a secondary one in the other. AML-specific variants were identified in both. Real-time RT-PCR experiments demonstrated that CD25 mRNA is overexpressed in advanced-phase CML compared to AML. Unsupervised principal component analysis showed that AML harboring a BCR::ABL1 fusion was clustered within AML. An AML vs. myeloid BC-CML differential expression signature was highlighted, and while ID4 (inhibitor of DNA binding 4) mRNA appears undetectable in most myeloid BC-CML samples, low levels are detected in AML samples. Therefore, CD25 and ID4 mRNA expression might differentiate AML with BCR::ABL1 from BC-CML and assign it to the AML group. A method for identifying this new WHO entity is then proposed. Finally, the hypothesis of AML with BCR::ABL1 arising from driver mutations on a BCR::ABL1 background behaving as a clonal hematopoiesis mutation is discussed. Validation of our data in larger cohorts and basic research are needed to better understand the molecular and cellular aspects of AML with a BCR::ABL1 entity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU de Poitiers, Service de Cancérologie Biologique, F86000 Poitiers, France.
- Faculté de Médecine, Université Paris Saclay, F94270 Le Kremlin-Bicêtre, France.
- CHU de Poitiers, Service d'Hématologie Biologique, F86000 Poitiers, France.
- CHU de Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, F86000 Poitiers, France.
- INSERM, CIC-P 1402, F86000 Poitiers, France.
- INSERM U1310, F94807 Villejuif, France.
ORCID-Profile: Christophe Desterke, Anna Raimbault, Annelise Bennaceur-Griscelli, Ali G Turhan, Jean-Claude Chomel
Zitieren
APA
Boucher, L., Sorel, N., Desterke, C., Chollet, M., Rozalska, L., Gallego Hernanz, M. P., Cayssials, E., Raimbault, A., Bennaceur-Griscelli, A., Turhan, A. G., & Chomel, J. C. (2023). Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015441
Vancouver
Boucher L, Sorel N, Desterke C, Chollet M, Rozalska L, Gallego Hernanz MP, et al. Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015441
BibTeX
@article{Boucher2023,
author = {Boucher, Lara and Sorel, Nathalie and Desterke, Christophe and Chollet, Mélanie and Rozalska, Laura and Gallego Hernanz, Maria Pilar and Cayssials, Emilie and Raimbault, Anna and Bennaceur-Griscelli, Annelise and Turhan, Ali G and Chomel, Jean-Claude},
title = {Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242015441}
}
EUVIMED